Oncology
Harry Erba, MD
Professor of Medicine, Duke University School of Medicine; Director, Leukemia Program; Director, Phase I Development in Hematologic Malignancies
Harry P. Erba, MD, PhD, is a hematologic oncologist specializing in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPN), including chronic myeloid leukemia, polycythemia vera, essential thrombocythemia, and myelofibrosis. He primarily serves adults with these life-threatening blood cancers, including those eligible for phase I trials and investigational therapies targeting molecular abnormalities specific to le
35+
Years in Practice
Credentials
Education & Training
- Stanford University — MD, PhD
- Brigham and Women’s Hospital, Harvard Medical School — Residency and Research/Clinical Fellowship, Medicine
Peer Recognition
- Castle Connolly — Top Doctor
2007-2026 (20 years)
Recognition & Leadership
Leadership Roles
- Director, Leukemia Program
- Director, Phase I Development in Hematologic Malignancies
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Duke Cancer Institute
- Duke University Hospital
Languages
English
Experience
35+ years in practice